DprE1-IN-1

CAS No. 1494675-86-3

DprE1-IN-1( TBA-7371 | TBA 7371 | TBA7371 )

Catalog No. M17323 CAS No. 1494675-86-3

DprE1-IN-1 is a potent inhibitor of DprE1 and PDE6.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 27 In Stock
5MG 41 In Stock
10MG 61 In Stock
25MG 113 In Stock
50MG 186 In Stock
100MG 317 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DprE1-IN-1
  • Note
    Research use only, not for human use.
  • Brief Description
    DprE1-IN-1 is a potent inhibitor of DprE1 and PDE6.
  • Description
    TBA-7371 is a non-covalent inhibitor of decaprenylphosphoryl-β-D-ribose 2’-epimerase (DprE1) with an IC50 value of 10 nM. It also inhibits PDE6 with an IC50 value of 4 μM.1 AZ 7371 has been shown to be active against M. tuberculosis with an MIC range of 0.78-3.12 μM and demonstrates efficacy in a rodent model of tuberculosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    TBA-7371 | TBA 7371 | TBA7371
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    DprE1
  • Research Area
    Infection|Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    1494675-86-3
  • Formula Weight
    355.39
  • Molecular Formula
    C18H21N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 11 mg/mL. 30.95 mM;
  • SMILES
    Cc1cc2c(c(cn2Cc2c(c(ncn2)OC)C)C(=O)NCCO)nc1
  • Chemical Name
    N-(2-hydroxyethyl)-1-((6-methoxy-5-methylpyrimidin-4-yl)methyl)-6-methyl-1H-pyrrolo[3,2-b]pyridine-3-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shirude PS, et al. J Med Chem. 2014 Jul 10;57(13):5728-37.
molnova catalog
related products
  • ON-013100

    ON-013100 is an antineoplastic drug. ON-013100 also acts as a mitotic inhibitor that could inhibit Cyclin D1 expression.

  • Senexin-A

    A selective inhibitor of CDK8 (IC50=0.28 uM) and CDK19; inhibits CDK8 and CDK19 ATP site binding with Kd50 of 0.83 uM and 0.31 uM, respectively.

  • BMS-265246

    BMS-265246 is a potent and selective CDK1/2 inhibitor with IC50 of 6 nM/9 nM in a cell-free assay.